Description:

CALGB 10201 REGISTRATION WORKSHEET Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B228B8A4-E2DC-4D1A-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B228B8A4-E2DC-4D1A-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 12/18/14
  2. 1/9/15
  3. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Leukemia NCT00085124 Registration - CALGB 10201 REGISTRATION WORKSHEET - 2076520v3.0

A Phase III Study of Daunorubicin and Cytarabine +/- G3139 (Genasense) in Previously Untreated Patients with Acute Myeloid Leukemia

Protocol Administration
Patient Demographics/pre-treatment Characteristics
Gender
Race (Mark all that apply)
Ethnicity (Mark one)
Method of Payment (USA only)
Certification Of Eligibility
Is the patient eligible? (Stratification Factors)
Protocol Design
Type of AML
Assigned Treatment Arm
Initial Patient Consent For Specimen Use
Patient's Initial Consent given for Specimen use for research on the patient's cancer?
Patient's Initial Consent given for specimen use for research unrelated to the patient's cancer?
Patient's Initial Consent given for further contact regarding specimen?
Registration Information
Ccrr Module For Calgb 10201 Registration Worksheet

Similar models